79 related articles for article (PubMed ID: 12703348)
1. [Molecular and cytometric analysis of renal cell carcinoma cells. Concepts, techniques and prospects].
Li G; Lambert C; Gentil-Perret A; Genin C; Tostain J
Prog Urol; 2003 Feb; 13(1):1-13. PubMed ID: 12703348
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers for predicting prognosis of renal cell carcinoma.
Nogueira M; Kim HL
Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance for detection of circulating cancer cells in renal cell carcinoma].
Uemura H; Hirao Y
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1712-8. PubMed ID: 12402419
[TBL] [Abstract][Full Text] [Related]
5. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
6. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Belldegrun AS; Horvath S; Figlin RA
J Urol; 2005 May; 173(5):1496-501. PubMed ID: 15821467
[TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability.
Eichelberg C; Junker K; Ljungberg B; Moch H
Eur Urol; 2009 Apr; 55(4):851-63. PubMed ID: 19155123
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
[TBL] [Abstract][Full Text] [Related]
11. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
Receveur AO; Couturier J; MoliniƩ V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
[TBL] [Abstract][Full Text] [Related]
12. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray.
Abrahams NA; MacLennan GT; Khoury JD; Ormsby AH; Tamboli P; Doglioni C; Schumacher B; Tickoo SK
Histopathology; 2004 Dec; 45(6):593-602. PubMed ID: 15569050
[TBL] [Abstract][Full Text] [Related]
14. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
[TBL] [Abstract][Full Text] [Related]
15. Using protein expressions to predict survival in clear cell renal carcinoma.
Kim HL; Seligson D; Liu X; Janzen N; Bui MH; Yu H; Shi T; Figlin RA; Horvath S; Belldegrun AS
Clin Cancer Res; 2004 Aug; 10(16):5464-71. PubMed ID: 15328185
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
Delahunt B; Bethwaite PB; Nacey JN
Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
[TBL] [Abstract][Full Text] [Related]
17. Molecular prognostic factor in renal cell carcinoma.
Shimazui T; Oosterwijk E; Debruyne FM; Schalken JA
Semin Urol Oncol; 1996 Nov; 14(4):250-5. PubMed ID: 8946626
[TBL] [Abstract][Full Text] [Related]
18. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
19. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms.
Cheng L; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R
Hum Pathol; 2009 Jan; 40(1):10-29. PubMed ID: 19027455
[TBL] [Abstract][Full Text] [Related]
20. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]